Quanterix Stock Soars 15.05% on AD/PD Conference Showcase

Quanterix's stock surged by 15.05% in pre-market trading on April 1, 2025, marking a significant rise that has caught the attention of investors and analysts alike.

Quanterix has been actively showcasing its innovative Simoa® technology at the AD/PD conference in Vienna. The technology was featured in over 80 posters and oral presentations, highlighting its impact on neurodegenerative disease research. This extensive display of Simoa® technology underscores Quanterix's commitment to advancing scientific discovery in this critical area.

In addition to its technological showcases, Quanterix has introduced a new dried blood spot (DBS) extraction kit for its Simoa® assay platform. This new kit is designed to enhance the efficiency and accuracy of blood tests, particularly for conditions like Alzheimer's disease. The unveiling of this kit at the AD/PD conference further solidifies Quanterix's position as a leader in diagnostic innovation.